Rank: 11
2015 Rank7
R&D Spend:$7,232,000,000
Fiscal year ending:12-31-15
Click here to see all 100

Alcon's AcrySof IQ PanOptix trifocal intraocular lens won a recommendation for approval from and FDA advisory panel in November 2014; in June 2015 the device won CE Mark approval in the European Union. Novartis, Alcon's Swiss parent, struck a deal in July 2014 for Alcon to license Google's smart lens technology for medical use. In May 2014 Novartis replaced Kevin Buehler, who retired, with Sandoz chief Jeff George.

2015 Top 500 Solar Contractors Key Personnel: Mike Ball, CEO, Alcon; Laurent Attias, Head, Strategy, BD&L & Market Access, Alcon; Royce Bedward SVP, GC, Alcon; Ian Bell, President, EMEA, Alcon; Sergio Duplan, President, North America, Alcon; David Endicott, COO, Alcon; Camila Finzi President, Latin America & the Caribbean, Alcon; Franck Leveiller, Head, Global R&D, Alcon; Bettina Maunz, VP, Communications, Alcon; Merrick McCracken, SVP, HR, Alcon; Ed McGough, SVP, Manufacturing & Technical Operations, Alcon; Jim Murphy, President, Japan, Alcon; David Murray, CFO, Alcon; Michael Onuscheck, Global Franchise Head, Alcon Surgical; Dave Schoening, SVP, Quality, Alcon; Eric Van Oppens, President, Asia & Russia, Alcon; Robert Warner, Global Franchise Head, Alcon Vision Care; Sue Whitfill, Head, Global Quality, Alcon;

Basel, Basel